Market Overview

The US Oncology Network Promotes Leader in Value-Based Care Dr. Marcus Neubauer to Chief Medical Officer


Medical oncologist is appointed to spearhead The Network's
significant medical programs and collaborative, integrated approach to
cancer care

US Oncology Network
(The Network) announced the appointment of
Marcus Neubauer, M.D., as its chief medical officer, building on its
mission of delivering a comprehensive approach to cancer care. Michael
Seiden, M.D., Ph.D. will continue to lead The Network as its president.

Dr. Neubauer has been a practicing medical oncologist for over 20 years,
serving previously as a physician and leader in our Kansas City
practice. For the past five years he has served as the vice president
and medical director for payer, clinical services, and value-based care,
working with over 1,400 community oncologists across the country. He is
a recognized leader in innovation in clinical pathways, value-based care
and contracting and the Center for Medicare and Medicaid Innovation's
(CMMI®) Oncology Care Model.

Dr. Neubauer has served numerous appointments and committees, received
honors, awards and has been featured as a thought leader in publications
for the past 25 years. While serving The US Oncology Network, he has
continued his clinical activities in Seattle as an associate clinical
professor for the Seattle Cancer Care Alliance.

"I am thrilled to be continuing my career with The US Oncology Network
in this leadership role," said Dr. Neubauer. "It's an exciting
opportunity for me to help guide The Network's approach to cancer
treatment amid the many changes in the healthcare environment to ensure
comprehensive high-quality, value-based care in the community setting."

Dr. Neubauer has been the lead or contributing author on more than 60
original, peer-reviewed research articles, editorials and meeting
abstracts. In addition to his clinical work and medical-director role
for The Network, he has served on the Journal of Oncology Practice
editorial board for six years and is a current editorial board member
for the Community Oncology and Supportive Care Journal since 2012.

"After a national search for a chief medical officer, we are excited to
share that our well-respected physician-leader will serve in this
forward-thinking role," said Dr. Michael Seiden. "Dr. Neubauer will work
closely with Dr. Lucy Langer, chair of The US Oncology Network national
policy board and joins my executive committee effective July 16."

Dr. Neubauer is a board-certified, fellowship-trained medical oncologist
who earned his medical degree and completed his internship and residency
at the University of Kansas in Kansas City. He completed his oncology
fellowship at the University of Washington in Seattle. Dr. Neubauer will
establish residence and office in The Woodlands, TX.

About The US Oncology Network

The US Oncology Network is one of the nation's largest networks of
integrated, community-based oncology practices dedicated to advancing
high-quality, evidence-based cancer care. A physician-led organization,
The US Oncology Network unites like-minded physicians and clinicians
around a common vision of improving patient outcomes and quality of
life. Leveraging healthcare information technology, shared best
practices, evidence-based guidelines and quality measurements,
physicians within The US Oncology Network are pioneering new ways to
achieve this vision. The US Oncology Network is committed to
strengthening patient access to integrated care in local communities
across the nation, including collaboration with a variety of payers,
hospitals and academic institutions. The US Oncology Network is
supported by McKesson
Specialty Health
, a division of McKesson
 focused on empowering a vibrant and sustainable
community patient care delivery system. For more information, visit

About McKesson Specialty Health

McKesson Specialty Health, a division of McKesson Corporation, works
together with stakeholders across the healthcare delivery system to
preserve and strengthen specialty care, passionately driven by the
benefits it provides patients and the system as a whole. Through
innovative provider, practice management, biopharma and payer solutions,
McKesson Specialty Health focuses on improving the financial,
operational and business health of our customers and partners so they
may provide the best care to patients. At McKesson Specialty Health, we
believe that we are all in this together. For more information, visit

View Comments and Join the Discussion!